Psoriasis is a recurrent, chronic, immune-mediated, systemic inflammatory disease of the
skin, joints, and other organic systems. After atopic dermatitis, chronic stationary psoriasis is …

Over recent years, significant progress has been made in characterisation of the underlying
pathogenic mechanisms in psoriasis, a common cutaneous disease that is associated with …

Psoriasis is one of the most common T cell–mediated autoimmune diseases in humans.
Although a role for the innate immune system in driving the autoimmune T cell cascade has …

Background We analysed incidence, predictors, histological features and specific treatment
options of anti-tumour necrosis factor α (TNF-α) antibody-induced psoriasiform skin lesions …

One characteristic abnormality of lesional skin in psoriasis is the excessive production of
antimicrobial peptides and proteins (AMPs). AMPs typically are small (12–50 amino acids) …

Background Psoriasis is an immune-mediated disease characterized by aberrant epidermal
differentiation, surface scale formation, and marked cutaneous inflammation. To better …

Narrow-band ultraviolet-B (NB-UVB) phototherapy is an effective treatment for psoriasis. The
molecular mechanisms underlying its efficacy are incompletely understood. To identify NB …

Much progress has been made in our understanding of Interferon biology since its initial
description by Isaacs and Lindenmann in 1957.[1] Type I Interferons have well established …

Psoriasis is one of the commonest chronic inflammatory disorders. Its cause is unknown, but
a wealth of studies indicate that the disease results from a complex and dynamic interplay …

We report the provocation of localized psoriasis at the sites of application of topical
imiquimod, possibly evolving into a generalized flare. A patient with pre‐existing psoriasis …